Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1607)	9/14/2000 4:39:01 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 52153

Thanks Peter, It appears to me that the tradeoff will be the risk to the doctor of malpractice by using a more risky procedure versus the revenue to the doctor of doing the invasive one. With HMO's pushing the cost advantage of BioZ and doctors fear of malpractice - BioZ seems the likely winner. From what I know of GE your suggestion they might buy the company is reasonable. So I bought some. I also like your QTRN suggestion but have not bought yet. ij

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next